Neural Regulation of Innate Immunity in Inflammatory Skin Diseases

As the largest barrier organ of the body, the skin is highly innervated by peripheral sensory neurons. The major function of these sensory neurons is to transmit sensations of temperature, pain, and itch to elicit protective responses. Inflammatory skin diseases are triggered by the aberrant activat...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaobao Huang (Author), Fengxian Li (Author), Fang Wang (Author)
Format: Book
Published: MDPI AG, 2023-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_6a9cc9eeb0984aa08e3a3b8d38c94f10
042 |a dc 
100 1 0 |a Xiaobao Huang  |e author 
700 1 0 |a Fengxian Li  |e author 
700 1 0 |a Fang Wang  |e author 
245 0 0 |a Neural Regulation of Innate Immunity in Inflammatory Skin Diseases 
260 |b MDPI AG,   |c 2023-02-01T00:00:00Z. 
500 |a 10.3390/ph16020246 
500 |a 1424-8247 
520 |a As the largest barrier organ of the body, the skin is highly innervated by peripheral sensory neurons. The major function of these sensory neurons is to transmit sensations of temperature, pain, and itch to elicit protective responses. Inflammatory skin diseases are triggered by the aberrant activation of immune responses. Recently, increasing evidence has shown that the skin peripheral nervous system also acts as a regulator of immune responses, particularly innate immunity, in various skin inflammatory processes. Meanwhile, immune cells in the skin can express receptors that respond to neuropeptides/neurotransmitters, leading to crosstalk between the immune system and nervous system. Herein, we highlight recent advances of such bidirectional neuroimmune interactions in certain inflammatory skin conditions. 
546 |a EN 
690 |a innate immunity 
690 |a neuropeptide 
690 |a neural regulation 
690 |a atopic dermatitis 
690 |a psoriasis 
690 |a Medicine 
690 |a R 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceuticals, Vol 16, Iss 2, p 246 (2023) 
787 0 |n https://www.mdpi.com/1424-8247/16/2/246 
787 0 |n https://doaj.org/toc/1424-8247 
856 4 1 |u https://doaj.org/article/6a9cc9eeb0984aa08e3a3b8d38c94f10  |z Connect to this object online.